Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-195-5p ABCB7 -0.03 0.96455 -0.14 0.83141 miRNAWalker2 validate -0.1 0.0037 NA
2 hsa-miR-338-3p ABI3BP 0.26 0.82352 -0.37 0.41633 miRanda -0.34 0.00054 NA
3 hsa-miR-15a-5p ABL2 0.11 0.90237 0.04 0.95748 MirTarget; miRNATAP -0.16 5.0E-5 NA
4 hsa-miR-15b-5p ABL2 -0.01 0.99463 0.04 0.95748 MirTarget; miRNATAP -0.12 0.00091 NA
5 hsa-miR-16-5p ABL2 0.17 0.88456 0.04 0.95748 miRNAWalker2 validate; MirTarget; miRNATAP -0.13 0.00034 NA
6 hsa-miR-15b-5p ABTB2 -0.01 0.99463 0.2 0.73094 MirTarget -0.14 0.0318 NA
7 hsa-miR-16-5p ACTN1 0.17 0.88456 -0.04 0.97262 miRNAWalker2 validate -0.25 0 NA
8 hsa-miR-365a-3p ADAM10 0.14 0.82522 -0.21 0.80651 MirTarget -0.18 0.00039 NA
9 hsa-miR-338-3p ADAM11 0.26 0.82352 0.11 0.80369 mirMAP -0.2 0.01167 NA
10 hsa-miR-338-3p ADAMTS1 0.26 0.82352 0.03 0.96886 miRanda -0.13 0.01943 NA
11 hsa-miR-15a-5p ADAMTS18 0.11 0.90237 -0.6 0.24444 miRNATAP -1 0 NA
12 hsa-miR-15b-5p ADAMTS18 -0.01 0.99463 -0.6 0.24444 miRNATAP -1.03 0 NA
13 hsa-miR-16-5p ADAMTS18 0.17 0.88456 -0.6 0.24444 miRNATAP -1.09 0 NA
14 hsa-miR-424-5p ADAMTS18 0.15 0.87662 -0.6 0.24444 miRNATAP -0.49 2.0E-5 NA
15 hsa-miR-15a-5p ADAMTS3 0.11 0.90237 -0.15 0.57772 miRNATAP -0.59 0 NA
16 hsa-miR-15b-5p ADAMTS3 -0.01 0.99463 -0.15 0.57772 miRNATAP -0.62 0 NA
17 hsa-miR-16-5p ADAMTS3 0.17 0.88456 -0.15 0.57772 miRNATAP -0.71 0 NA
18 hsa-miR-424-5p ADAMTS3 0.15 0.87662 -0.15 0.57772 miRNATAP -0.18 0.00813 NA
19 hsa-miR-15a-5p ADAMTS5 0.11 0.90237 0.35 0.38267 miRNATAP -0.39 0 NA
20 hsa-miR-15b-5p ADAMTS5 -0.01 0.99463 0.35 0.38267 miRNATAP -0.45 0 NA
21 hsa-miR-16-5p ADAMTS5 0.17 0.88456 0.35 0.38267 miRNATAP -0.46 0 NA
22 hsa-miR-338-3p ADAMTS6 0.26 0.82352 0.02 0.94873 miRNATAP -0.16 0.01117 NA
23 hsa-miR-15a-5p ADAMTSL3 0.11 0.90237 -0.2 0.64161 MirTarget -1.46 0 NA
24 hsa-miR-15b-5p ADAMTSL3 -0.01 0.99463 -0.2 0.64161 MirTarget -1.23 0 NA
25 hsa-miR-16-5p ADAMTSL3 0.17 0.88456 -0.2 0.64161 MirTarget -1.39 0 NA
26 hsa-miR-424-5p ADAMTSL3 0.15 0.87662 -0.2 0.64161 MirTarget -0.49 4.0E-5 NA
27 hsa-miR-15a-5p ADCY1 0.11 0.90237 0.38 0.25371 mirMAP -0.32 0.01019 NA
28 hsa-miR-15b-5p ADCY1 -0.01 0.99463 0.38 0.25371 mirMAP -0.28 0.01699 NA
29 hsa-miR-16-5p ADCY1 0.17 0.88456 0.38 0.25371 mirMAP -0.39 0.00084 NA
30 hsa-miR-16-5p ADCY2 0.17 0.88456 0.09 0.80312 mirMAP -1.08 0 NA
31 hsa-miR-15a-5p ADCY5 0.11 0.90237 -0.55 0.2334 MirTarget; miRNATAP -1.61 0 NA
32 hsa-miR-15b-5p ADCY5 -0.01 0.99463 -0.55 0.2334 MirTarget; miRNATAP -1.39 0 NA
33 hsa-miR-16-5p ADCY5 0.17 0.88456 -0.55 0.2334 MirTarget; miRNATAP -1.48 0 NA
34 hsa-miR-424-5p ADCY5 0.15 0.87662 -0.55 0.2334 MirTarget; miRNATAP -0.54 3.0E-5 NA
35 hsa-miR-24-3p ADCY9 0.01 0.99378 -0.21 0.75553 miRNATAP -0.31 0.00075 NA
36 hsa-miR-24-3p ADD2 0.01 0.99378 -0.16 0.76694 MirTarget -0.86 0.00351 NA
37 hsa-miR-365a-3p ADD3 0.14 0.82522 -0.06 0.9558 MirTarget; miRNATAP -0.11 0.04146 NA
38 hsa-miR-15a-5p ADRB2 0.11 0.90237 -0.01 0.98489 MirTarget -0.79 0 NA
39 hsa-miR-15b-5p ADRB2 -0.01 0.99463 -0.01 0.98489 MirTarget -0.53 1.0E-5 NA
40 hsa-miR-16-5p ADRB2 0.17 0.88456 -0.01 0.98489 MirTarget -0.67 0 NA
41 hsa-miR-338-3p ADRB2 0.26 0.82352 -0.01 0.98489 miRanda -0.23 0.0054 NA
42 hsa-miR-424-5p ADRB2 0.15 0.87662 -0.01 0.98489 MirTarget -0.49 0 NA
43 hsa-miR-497-5p AEBP2 -0.16 0.77126 -0.02 0.98064 MirTarget -0.14 1.0E-5 NA
44 hsa-miR-15a-5p AFF4 0.11 0.90237 -0.1 0.9096 MirTarget; miRNATAP -0.11 0.00251 NA
45 hsa-miR-15a-5p AGPAT4 0.11 0.90237 0.33 0.44742 mirMAP -0.46 2.0E-5 NA
46 hsa-miR-15b-5p AGPAT4 -0.01 0.99463 0.33 0.44742 mirMAP -0.29 0.00568 NA
47 hsa-miR-16-5p AGPAT4 0.17 0.88456 0.33 0.44742 mirMAP -0.41 6.0E-5 NA
48 hsa-miR-24-3p AGPAT4 0.01 0.99378 0.33 0.44742 mirMAP -0.41 0.02691 NA
49 hsa-miR-424-5p AGPAT4 0.15 0.87662 0.33 0.44742 mirMAP -0.25 0.00083 NA
50 hsa-miR-16-5p AHNAK2 0.17 0.88456 0.12 0.8803 miRNAWalker2 validate -0.67 0 NA
51 hsa-miR-338-3p AIF1L 0.26 0.82352 0.17 0.69229 miRanda -0.15 0.0389 NA
52 hsa-miR-365a-3p AKAP10 0.14 0.82522 -0.03 0.9509 MirTarget -0.13 0.00089 NA
53 hsa-miR-338-3p AKAP12 0.26 0.82352 0.17 0.82172 miRanda -0.26 0.00378 NA
54 hsa-miR-16-5p AKAP13 0.17 0.88456 -0.19 0.84518 miRNAWalker2 validate -0.17 0.00038 NA
55 hsa-miR-24-3p AKAP13 0.01 0.99378 -0.19 0.84518 mirMAP -0.2 0.02409 NA
56 hsa-miR-15a-5p AKT3 0.11 0.90237 0.06 0.90908 miRNAWalker2 validate; miRTarBase; miRNATAP -0.72 0 NA
57 hsa-miR-15b-5p AKT3 -0.01 0.99463 0.06 0.90908 miRNATAP -0.67 0 NA
58 hsa-miR-16-5p AKT3 0.17 0.88456 0.06 0.90908 miRNAWalker2 validate; miRTarBase; miRNATAP -0.75 0 NA
59 hsa-miR-424-5p AKT3 0.15 0.87662 0.06 0.90908 miRNATAP -0.24 0.00104 26315541 Silencing Akt3 and E2F3 by siRNA pheno-copied the effect of ectopic miR-424 on HCC growth; Whereas overexpression of Akt3 and E2F3 attenuated the effect of miR-424 on HCC growth
60 hsa-miR-497-5p ALDH9A1 -0.16 0.77126 0.01 0.98723 miRNAWalker2 validate -0.13 0.00037 NA
61 hsa-miR-338-3p AMACR 0.26 0.82352 0.02 0.98492 miRanda -0.15 0.01357 NA
62 hsa-miR-15a-5p AMOTL1 0.11 0.90237 -0.11 0.85689 MirTarget; miRNATAP -0.94 0 NA
63 hsa-miR-15b-5p AMOTL1 -0.01 0.99463 -0.11 0.85689 MirTarget; miRNATAP -0.82 0 NA
64 hsa-miR-16-5p AMOTL1 0.17 0.88456 -0.11 0.85689 MirTarget; miRNATAP -0.93 0 NA
65 hsa-miR-424-5p AMOTL1 0.15 0.87662 -0.11 0.85689 MirTarget; miRNATAP -0.28 0.00057 NA
66 hsa-miR-16-5p AMPD1 0.17 0.88456 0.03 0.96951 miRNAWalker2 validate -0.39 0.02119 NA
67 hsa-miR-338-3p ANGPTL7 0.26 0.82352 -0.01 0.99351 miRanda -0.24 0.03118 NA
68 hsa-miR-15a-5p ANK2 0.11 0.90237 0.04 0.93166 MirTarget; miRNATAP -1.21 0 NA
69 hsa-miR-15b-5p ANK2 -0.01 0.99463 0.04 0.93166 MirTarget; miRNATAP -0.99 0 NA
70 hsa-miR-16-5p ANK2 0.17 0.88456 0.04 0.93166 MirTarget; miRNATAP -1.11 0 NA
71 hsa-miR-424-5p ANK2 0.15 0.87662 0.04 0.93166 MirTarget; miRNATAP -0.46 0 NA
72 hsa-miR-365a-3p ANKRD11 0.14 0.82522 -0.1 0.92248 MirTarget -0.1 0.00317 NA
73 hsa-miR-365a-3p ANKRD12 0.14 0.82522 -0.2 0.77041 miRNAWalker2 validate -0.1 0.03571 NA
74 hsa-miR-15a-5p ANKRD29 0.11 0.90237 0.28 0.38764 MirTarget -0.39 0.00308 NA
75 hsa-miR-15b-5p ANKRD29 -0.01 0.99463 0.28 0.38764 MirTarget -0.33 0.00839 NA
76 hsa-miR-16-5p ANKRD29 0.17 0.88456 0.28 0.38764 MirTarget -0.34 0.00575 NA
77 hsa-miR-24-3p ANKRD44 0.01 0.99378 -0.34 0.2301 MirTarget -0.82 0 NA
78 hsa-miR-497-5p ANKRD46 -0.16 0.77126 -0.09 0.89134 MirTarget -0.19 0.00093 NA
79 hsa-miR-24-3p ANKRD52 0.01 0.99378 -0.15 0.86716 mirMAP; miRNATAP -0.16 0.01929 NA
80 hsa-miR-365a-3p ANKS1A 0.14 0.82522 -0.12 0.88556 MirTarget -0.12 0.00063 NA
81 hsa-miR-24-3p ANPEP 0.01 0.99378 -0.06 0.94546 miRNAWalker2 validate -0.77 0.00709 NA
82 hsa-miR-24-3p AOC3 0.01 0.99378 -0.07 0.92679 MirTarget -0.97 1.0E-5 NA
83 hsa-miR-338-3p AP1S2 0.26 0.82352 0.12 0.80192 MirTarget; PITA; miRanda -0.12 0.00569 NA
84 hsa-miR-15b-5p AP4S1 -0.01 0.99463 0.14 0.51545 miRNAWalker2 validate -0.14 0.02221 NA
85 hsa-miR-195-5p APLN -0.03 0.96455 0.14 0.78303 MirTarget; miRNATAP -0.29 0.00108 NA
86 hsa-miR-497-5p APLN -0.16 0.77126 0.14 0.78303 MirTarget; miRNATAP -0.3 0.00402 NA
87 hsa-miR-15a-5p APLNR 0.11 0.90237 0.01 0.99326 MirTarget -0.35 0.00048 NA
88 hsa-miR-15b-5p APLNR -0.01 0.99463 0.01 0.99326 MirTarget -0.45 0 NA
89 hsa-miR-16-5p APLNR 0.17 0.88456 0.01 0.99326 miRNAWalker2 validate; MirTarget -0.5 0 NA
90 hsa-miR-424-5p APLNR 0.15 0.87662 0.01 0.99326 MirTarget -0.17 0.01321 NA
91 hsa-miR-338-3p APOLD1 0.26 0.82352 0.35 0.649 miRanda -0.18 0.02782 NA
92 hsa-miR-15a-5p APP 0.11 0.90237 -0.18 0.89833 miRNAWalker2 validate; miRNATAP -0.14 0.00073 NA
93 hsa-miR-16-5p APP 0.17 0.88456 -0.18 0.89833 miRNAWalker2 validate; miRNATAP -0.13 0.00084 NA
94 hsa-miR-15a-5p AR 0.11 0.90237 -0.54 0.32591 mirMAP; miRNATAP -1.06 0 NA
95 hsa-miR-15b-5p AR -0.01 0.99463 -0.54 0.32591 mirMAP; miRNATAP -0.74 0 NA
96 hsa-miR-16-5p AR 0.17 0.88456 -0.54 0.32591 mirMAP; miRNATAP -1.03 0 NA
97 hsa-miR-424-5p AR 0.15 0.87662 -0.54 0.32591 mirMAP; miRNATAP -0.39 0.00132 NA
98 hsa-miR-24-3p ARHGAP19 0.01 0.99378 -0.18 0.7396 miRNAWalker2 validate -0.19 0.01101 NA
99 hsa-miR-15a-5p ARHGAP20 0.11 0.90237 0.1 0.77766 MirTarget; miRNATAP -0.85 0 NA
100 hsa-miR-15b-5p ARHGAP20 -0.01 0.99463 0.1 0.77766 MirTarget; miRNATAP -0.66 0 NA
101 hsa-miR-16-5p ARHGAP20 0.17 0.88456 0.1 0.77766 MirTarget; miRNATAP -0.76 0 NA
102 hsa-miR-424-5p ARHGAP20 0.15 0.87662 0.1 0.77766 MirTarget; miRNATAP -0.3 0.00145 NA
103 hsa-miR-195-5p ARHGAP32 -0.03 0.96455 -0.3 0.74947 MirTarget -0.1 0.04152 NA
104 hsa-miR-497-5p ARHGAP5 -0.16 0.77126 -0.05 0.95466 MirTarget; miRNATAP -0.13 0.00179 NA
105 hsa-miR-338-3p ARHGAP6 0.26 0.82352 -0.42 0.35366 miRanda -0.26 0.00512 NA
106 hsa-miR-24-3p ARID5B 0.01 0.99378 -0.16 0.85098 miRNATAP -0.17 0.04216 NA
107 hsa-miR-497-5p ARIH1 -0.16 0.77126 -0.1 0.90959 MirTarget -0.11 0.0003 NA
108 hsa-miR-16-5p ARL10 0.17 0.88456 -0.24 0.42733 miRNAWalker2 validate -0.67 0 NA
109 hsa-miR-24-3p ARL10 0.01 0.99378 -0.24 0.42733 mirMAP -0.73 9.0E-5 NA
110 hsa-miR-15a-5p ARL2 0.11 0.90237 0.02 0.97901 MirTarget; miRNATAP -0.11 0.01332 NA
111 hsa-miR-15a-5p ARMCX2 0.11 0.90237 0.29 0.5542 MirTarget; miRNATAP -0.57 0 NA
112 hsa-miR-15b-5p ARMCX2 -0.01 0.99463 0.29 0.5542 MirTarget; miRNATAP -0.46 0 NA
113 hsa-miR-16-5p ARMCX2 0.17 0.88456 0.29 0.5542 miRNAWalker2 validate; MirTarget; miRNATAP -0.5 0 NA
114 hsa-miR-338-3p ARMCX3 0.26 0.82352 0.03 0.9666 MirTarget; PITA; miRanda -0.14 0.00164 NA
115 hsa-miR-15a-5p ARNT2 0.11 0.90237 -0.47 0.3134 mirMAP -0.78 0 NA
116 hsa-miR-15b-5p ARNT2 -0.01 0.99463 -0.47 0.3134 mirMAP -0.51 0.00018 NA
117 hsa-miR-16-5p ARNT2 0.17 0.88456 -0.47 0.3134 mirMAP -0.73 0 NA
118 hsa-miR-424-5p ARNT2 0.15 0.87662 -0.47 0.3134 mirMAP -0.32 0.00156 NA
119 hsa-miR-338-3p ARSB 0.26 0.82352 -0.08 0.88514 miRanda -0.16 2.0E-5 NA
120 hsa-miR-15b-5p ASB1 -0.01 0.99463 -0.08 0.90098 MirTarget -0.15 0 NA
121 hsa-miR-16-5p ASB1 0.17 0.88456 -0.08 0.90098 MirTarget -0.11 0.00103 NA
122 hsa-miR-15a-5p ASH1L 0.11 0.90237 -0.14 0.87278 MirTarget; miRNATAP -0.12 0.00706 NA
123 hsa-miR-15a-5p ASTN1 0.11 0.90237 0.05 0.94222 MirTarget -1.25 0 NA
124 hsa-miR-15b-5p ASTN1 -0.01 0.99463 0.05 0.94222 MirTarget -0.98 0 NA
125 hsa-miR-16-5p ASTN1 0.17 0.88456 0.05 0.94222 MirTarget -1.12 0 NA
126 hsa-miR-424-5p ASTN1 0.15 0.87662 0.05 0.94222 MirTarget -0.53 0 NA
127 hsa-miR-15a-5p ASXL2 0.11 0.90237 -0.3 0.6827 miRNAWalker2 validate -0.13 0.03086 NA
128 hsa-miR-16-5p ASXL2 0.17 0.88456 -0.3 0.6827 miRNAWalker2 validate -0.24 1.0E-5 NA
129 hsa-miR-15a-5p ATF2 0.11 0.90237 -0.24 0.68896 miRNAWalker2 validate -0.12 0.00218 NA
130 hsa-miR-497-5p ATF6 -0.16 0.77126 -0.07 0.93596 MirTarget -0.1 0.0026 NA
131 hsa-miR-338-3p ATL1 0.26 0.82352 0.03 0.93523 miRanda -0.14 0.00195 NA
132 hsa-miR-338-3p ATP10D 0.26 0.82352 -0.06 0.91566 MirTarget; miRanda -0.11 0.01855 NA
133 hsa-miR-24-3p ATP1B2 0.01 0.99378 -0.1 0.73974 MirTarget -0.57 0.00576 NA
134 hsa-miR-195-5p ATP5G3 -0.03 0.96455 0.02 0.98733 MirTarget -0.11 0.00355 NA
135 hsa-miR-497-5p ATP5G3 -0.16 0.77126 0.02 0.98733 MirTarget -0.21 0 NA
136 hsa-miR-195-5p ATP6V1B2 -0.03 0.96455 -0.09 0.91984 MirTarget -0.11 0.02034 NA
137 hsa-miR-424-5p ATP6V1B2 0.15 0.87662 -0.09 0.91984 MirTarget -0.11 0.00231 NA
138 hsa-miR-16-5p ATP7A 0.17 0.88456 -0.27 0.64893 MirTarget -0.11 0.01109 NA
139 hsa-miR-338-3p ATRN 0.26 0.82352 -0.46 0.56279 MirTarget; miRanda -0.17 0.00015 NA
140 hsa-miR-24-3p ATRX 0.01 0.99378 -0.24 0.77958 MirTarget -0.14 0.0422 NA
141 hsa-miR-15a-5p ATXN1L 0.11 0.90237 -0.14 0.85841 miRNATAP -0.11 0.00148 NA
142 hsa-miR-16-5p ATXN1L 0.17 0.88456 -0.14 0.85841 miRNATAP -0.1 0.0019 NA
143 hsa-miR-24-3p AXL 0.01 0.99378 -0 0.99896 miRNATAP -0.55 0.00086 NA
144 hsa-miR-24-3p B3GALT5 0.01 0.99378 0.58 0.26646 MirTarget -0.82 0.01185 NA
145 hsa-miR-15a-5p BACE1 0.11 0.90237 -0.16 0.82465 miRNAWalker2 validate; miRNATAP -0.33 0 NA
146 hsa-miR-15b-5p BACE1 -0.01 0.99463 -0.16 0.82465 miRNATAP -0.3 0 NA
147 hsa-miR-16-5p BACE1 0.17 0.88456 -0.16 0.82465 miRNATAP -0.33 0 NA
148 hsa-miR-15a-5p BACH2 0.11 0.90237 -0.35 0.26727 MirTarget; miRNATAP -0.78 0 NA
149 hsa-miR-15b-5p BACH2 -0.01 0.99463 -0.35 0.26727 MirTarget; miRNATAP -0.65 0 NA
150 hsa-miR-16-5p BACH2 0.17 0.88456 -0.35 0.26727 MirTarget; miRNATAP -0.69 0 NA
NumGOOverlapSizeP ValueAdj. P Value
1 NEUROGENESIS 176 1402 1.168e-25 5.437e-22
2 CARDIOVASCULAR SYSTEM DEVELOPMENT 109 788 4.498e-19 6.977e-16
3 CIRCULATORY SYSTEM DEVELOPMENT 109 788 4.498e-19 6.977e-16
4 NEURON DIFFERENTIATION 116 874 7.933e-19 9.228e-16
5 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 179 1672 2.016e-18 1.738e-15
6 CELL DEVELOPMENT 160 1426 2.241e-18 1.738e-15
7 CELLULAR COMPONENT MORPHOGENESIS 117 900 2.818e-18 1.873e-15
8 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 81 513 9.043e-18 5.26e-15
9 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 120 957 1.717e-17 8.878e-15
10 REGULATION OF CELL DIFFERENTIATION 162 1492 3.047e-17 1.418e-14
11 VASCULATURE DEVELOPMENT 75 469 7.597e-17 3.213e-14
12 REGULATION OF CELL DEVELOPMENT 107 836 2.682e-16 1.04e-13
13 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 98 750 1.391e-15 4.979e-13
14 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 140 1275 2.43e-15 8.075e-13
15 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 129 1142 4.091e-15 1.269e-12
16 REGULATION OF NEURON DIFFERENTIATION 79 554 8.152e-15 2.371e-12
17 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 118 1021 1.371e-14 3.752e-12
18 TISSUE DEVELOPMENT 155 1518 3.483e-14 9.003e-12
19 BIOLOGICAL ADHESION 117 1032 6.924e-14 1.696e-11
20 REGULATION OF CELLULAR COMPONENT MOVEMENT 95 771 1.464e-13 3.407e-11
21 TISSUE MORPHOGENESIS 74 533 2.373e-13 5.258e-11
22 NEURON DEVELOPMENT 87 687 3.593e-13 7.598e-11
23 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 142 1395 6.192e-13 1.253e-10
24 NEURON PROJECTION DEVELOPMENT 74 545 7.34e-13 1.423e-10
25 LOCOMOTION 120 1114 1.131e-12 2.105e-10
26 POSITIVE REGULATION OF LOCOMOTION 62 420 1.507e-12 2.697e-10
27 CENTRAL NERVOUS SYSTEM DEVELOPMENT 100 872 2.68e-12 4.618e-10
28 BLOOD VESSEL MORPHOGENESIS 56 364 3.448e-12 5.73e-10
29 NEURON PROJECTION MORPHOGENESIS 59 402 6.754e-12 1.084e-09
30 REGULATION OF DEVELOPMENTAL GROWTH 48 289 7.737e-12 1.2e-09
31 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 62 437 8.61e-12 1.292e-09
32 POSITIVE REGULATION OF CELL DEVELOPMENT 65 472 1.019e-11 1.482e-09
33 PROTEIN PHOSPHORYLATION 104 944 1.097e-11 1.547e-09
34 CELL MOTILITY 95 835 1.534e-11 2.04e-09
35 LOCALIZATION OF CELL 95 835 1.534e-11 2.04e-09
36 REGULATION OF CELL PROJECTION ORGANIZATION 72 558 1.756e-11 2.249e-09
37 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 83 689 1.789e-11 2.249e-09
38 INTRACELLULAR SIGNAL TRANSDUCTION 150 1572 1.92e-11 2.351e-09
39 REGULATION OF NEURON PROJECTION DEVELOPMENT 58 408 3.781e-11 4.511e-09
40 TAXIS 63 464 3.926e-11 4.567e-09
41 CELL PROJECTION ORGANIZATION 99 902 4.423e-11 4.92e-09
42 ANGIOGENESIS 47 293 4.441e-11 4.92e-09
43 REGULATION OF CELL MORPHOGENESIS 70 552 7.455e-11 8.067e-09
44 POSITIVE REGULATION OF CELL DIFFERENTIATION 92 823 8.502e-11 8.991e-09
45 POSITIVE REGULATION OF RESPONSE TO STIMULUS 172 1929 1.307e-10 1.329e-08
46 HEART DEVELOPMENT 62 466 1.314e-10 1.329e-08
47 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 53 368 1.638e-10 1.622e-08
48 HEAD DEVELOPMENT 82 709 1.83e-10 1.774e-08
49 POSITIVE REGULATION OF NEURON DIFFERENTIATION 47 306 2.025e-10 1.885e-08
50 REGULATION OF CELL PROLIFERATION 141 1496 1.999e-10 1.885e-08
51 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 103 983 2.532e-10 2.31e-08
52 EMBRYO DEVELOPMENT 96 894 2.922e-10 2.615e-08
53 NEGATIVE REGULATION OF CELL DIFFERENTIATION 73 609 3.873e-10 3.4e-08
54 MORPHOGENESIS OF AN EPITHELIUM 55 400 4.332e-10 3.733e-08
55 POSITIVE REGULATION OF CELL PROLIFERATION 89 814 5.472e-10 4.629e-08
56 REGULATION OF ANATOMICAL STRUCTURE SIZE 61 472 5.998e-10 4.896e-08
57 ORGAN MORPHOGENESIS 91 841 5.923e-10 4.896e-08
58 REGULATION OF EXTENT OF CELL GROWTH 24 101 9.449e-10 7.58e-08
59 REGULATION OF CHEMOTAXIS 33 180 1.099e-09 8.664e-08
60 REGULATION OF ACTIN FILAMENT BASED PROCESS 46 312 1.236e-09 9.439e-08
61 TUBE DEVELOPMENT 67 552 1.237e-09 9.439e-08
62 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 38 232 1.759e-09 1.32e-07
63 POSITIVE REGULATION OF CELL COMMUNICATION 140 1532 1.859e-09 1.373e-07
64 RESPONSE TO GROWTH FACTOR 60 475 2.024e-09 1.471e-07
65 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 86 801 2.624e-09 1.878e-07
66 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 170 1977 2.68e-09 1.889e-07
67 MUSCLE STRUCTURE DEVELOPMENT 56 432 2.739e-09 1.902e-07
68 EMBRYONIC MORPHOGENESIS 65 539 2.854e-09 1.953e-07
69 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 161 1848 3.059e-09 2.033e-07
70 REGULATION OF TRANSPORT 158 1804 3.048e-09 2.033e-07
71 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 158 1805 3.169e-09 2.077e-07
72 POSITIVE REGULATION OF GENE EXPRESSION 153 1733 3.282e-09 2.121e-07
73 FOREBRAIN DEVELOPMENT 49 357 4.142e-09 2.64e-07
74 MESENCHYMAL CELL DIFFERENTIATION 27 134 4.277e-09 2.689e-07
75 NEGATIVE REGULATION OF CELL DEVELOPMENT 44 303 4.553e-09 2.825e-07
76 CELL PART MORPHOGENESIS 72 633 5.005e-09 3.064e-07
77 SKELETAL SYSTEM DEVELOPMENT 57 455 6.962e-09 4.207e-07
78 REGULATION OF PROTEIN MODIFICATION PROCESS 150 1710 7.386e-09 4.406e-07
79 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 29 156 8.015e-09 4.721e-07
80 REGULATION OF PHOSPHORUS METABOLIC PROCESS 143 1618 1.085e-08 6.309e-07
81 REGULATION OF GROWTH 71 633 1.147e-08 6.556e-07
82 CELL CELL ADHESION 69 608 1.155e-08 6.556e-07
83 REGULATION OF AXONOGENESIS 30 168 1.176e-08 6.592e-07
84 ACTIN FILAMENT BASED PROCESS 56 450 1.198e-08 6.634e-07
85 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 60 498 1.212e-08 6.636e-07
86 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 43 303 1.366e-08 7.389e-07
87 REGULATION OF CELLULAR COMPONENT SIZE 46 337 1.469e-08 7.858e-07
88 PHOSPHORYLATION 115 1228 1.617e-08 8.548e-07
89 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 39 262 1.71e-08 8.938e-07
90 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 32 191 1.915e-08 9.899e-07
91 REGULATION OF CELL SIZE 30 172 2.059e-08 1.053e-06
92 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 153 1784 2.293e-08 1.16e-06
93 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 45 337 4.106e-08 2.055e-06
94 EPITHELIUM DEVELOPMENT 93 945 4.311e-08 2.134e-06
95 CYTOSKELETON ORGANIZATION 85 838 4.483e-08 2.15e-06
96 REGULATION OF CELL ADHESION 69 629 4.481e-08 2.15e-06
97 BEHAVIOR 60 516 4.442e-08 2.15e-06
98 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 143 1656 4.656e-08 2.211e-06
99 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 73 684 5.573e-08 2.619e-06
100 MESENCHYME DEVELOPMENT 31 190 5.97e-08 2.778e-06
101 NEGATIVE REGULATION OF AXON EXTENSION 13 38 6.383e-08 2.941e-06
102 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 122 1360 6.562e-08 2.994e-06
103 RESPONSE TO ENDOGENOUS STIMULUS 128 1450 7.557e-08 3.414e-06
104 UROGENITAL SYSTEM DEVELOPMENT 41 299 7.822e-08 3.5e-06
105 RESPONSE TO OXYGEN LEVELS 42 311 8.406e-08 3.725e-06
106 CARDIAC CHAMBER DEVELOPMENT 26 144 8.694e-08 3.816e-06
107 TUBE MORPHOGENESIS 43 323 8.937e-08 3.886e-06
108 REGULATION OF AXON GUIDANCE 13 39 9.091e-08 3.917e-06
109 CELL SUBSTRATE ADHESION 28 164 9.678e-08 4.131e-06
110 REGULATION OF MEMBRANE POTENTIAL 44 343 1.86e-07 7.867e-06
111 MUSCLE TISSUE DEVELOPMENT 38 275 1.901e-07 7.97e-06
112 STEM CELL DIFFERENTIATION 30 190 2.041e-07 8.48e-06
113 NEGATIVE REGULATION OF CELL ADHESION 33 223 2.441e-07 1.005e-05
114 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 25 144 3.345e-07 1.365e-05
115 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 26 154 3.452e-07 1.373e-05
116 AMEBOIDAL TYPE CELL MIGRATION 26 154 3.452e-07 1.373e-05
117 NEURON PROJECTION GUIDANCE 31 205 3.45e-07 1.373e-05
118 NEGATIVE REGULATION OF AXONOGENESIS 16 65 3.499e-07 1.38e-05
119 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 22 117 4.071e-07 1.592e-05
120 REGULATION OF CELLULAR LOCALIZATION 113 1277 4.188e-07 1.624e-05
121 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 94 1008 4.373e-07 1.682e-05
122 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 88 926 4.672e-07 1.782e-05
123 ARTERY DEVELOPMENT 17 75 5.412e-07 2.047e-05
124 NEURON MIGRATION 21 110 5.711e-07 2.143e-05
125 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 18 84 6.161e-07 2.293e-05
126 SENSORY ORGAN DEVELOPMENT 55 493 6.208e-07 2.293e-05
127 MUSCLE ORGAN DEVELOPMENT 37 277 6.435e-07 2.358e-05
128 HEART MORPHOGENESIS 31 212 7.304e-07 2.655e-05
129 CARDIAC SEPTUM DEVELOPMENT 18 85 7.416e-07 2.675e-05
130 NEGATIVE CHEMOTAXIS 12 39 7.641e-07 2.735e-05
131 REGULATION OF HOMEOSTATIC PROCESS 51 447 8.119e-07 2.884e-05
132 NEGATIVE REGULATION OF AXON GUIDANCE 10 27 9.282e-07 3.272e-05
133 MUSCLE CELL DIFFERENTIATION 33 237 1.005e-06 3.517e-05
134 POSITIVE REGULATION OF GROWTH 33 238 1.106e-06 3.842e-05
135 CELL CELL SIGNALING 75 767 1.171e-06 4.036e-05
136 TELENCEPHALON DEVELOPMENT 32 228 1.224e-06 4.189e-05
137 NEGATIVE REGULATION OF LOCOMOTION 35 263 1.399e-06 4.752e-05
138 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 26 166 1.522e-06 5.132e-05
139 GLAND DEVELOPMENT 46 395 1.591e-06 5.325e-05
140 MAMMARY GLAND DEVELOPMENT 21 117 1.641e-06 5.455e-05
141 SINGLE ORGANISM CELL ADHESION 51 459 1.784e-06 5.889e-05
142 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 32 232 1.798e-06 5.891e-05
143 RESPONSE TO WOUNDING 59 563 1.922e-06 6.255e-05
144 POSITIVE REGULATION OF AXON EXTENSION 11 36 2.393e-06 7.541e-05
145 REGULATION OF CYTOSKELETON ORGANIZATION 54 502 2.399e-06 7.541e-05
146 SEMAPHORIN PLEXIN SIGNALING PATHWAY 11 36 2.393e-06 7.541e-05
147 NEGATIVE REGULATION OF CELL COMMUNICATION 104 1192 2.376e-06 7.541e-05
148 EXTRACELLULAR STRUCTURE ORGANIZATION 38 304 2.372e-06 7.541e-05
149 POSITIVE REGULATION OF CHEMOTAXIS 21 120 2.508e-06 7.832e-05
150 LOCOMOTORY BEHAVIOR 27 181 2.532e-06 7.853e-05
151 POSITIVE REGULATION OF MOLECULAR FUNCTION 144 1791 2.678e-06 8.252e-05
152 COGNITION 33 251 3.625e-06 0.0001103
153 OVULATION CYCLE 20 113 3.61e-06 0.0001103
154 PEPTIDYL TYROSINE MODIFICATION 27 186 4.291e-06 0.0001296
155 POSITIVE REGULATION OF AXONOGENESIS 15 69 4.356e-06 0.0001308
156 CEREBRAL CORTEX DEVELOPMENT 19 105 4.483e-06 0.0001337
157 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 100 1152 4.674e-06 0.0001385
158 CELL ACTIVATION 58 568 5.253e-06 0.0001547
159 IMMUNE SYSTEM DEVELOPMENT 59 582 5.462e-06 0.0001599
160 FOREBRAIN CELL MIGRATION 14 62 5.642e-06 0.0001641
161 NEGATIVE REGULATION OF CELL ACTIVATION 24 158 6.549e-06 0.0001893
162 REGULATION OF SYSTEM PROCESS 53 507 6.834e-06 0.0001963
163 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 20 118 7.148e-06 0.000204
164 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 91 1036 8.022e-06 0.0002262
165 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 91 1036 8.022e-06 0.0002262
166 REGULATION OF EPITHELIAL CELL PROLIFERATION 35 285 8.694e-06 0.0002437
167 AORTA DEVELOPMENT 11 41 9.745e-06 0.0002715
168 GROWTH 45 410 9.816e-06 0.0002719
169 CAMP METABOLIC PROCESS 10 34 1.011e-05 0.0002784
170 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 56 554 1.026e-05 0.0002808
171 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 11 1.036e-05 0.0002818
172 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 18 102 1.141e-05 0.0003087
173 EXTRACELLULAR MATRIX ASSEMBLY 7 16 1.156e-05 0.0003108
174 PALLIUM DEVELOPMENT 23 153 1.206e-05 0.0003226
175 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 88 1004 1.234e-05 0.000328
176 REGULATION OF MUSCLE TISSUE DEVELOPMENT 18 103 1.312e-05 0.0003469
177 MULTICELLULAR ORGANISMAL SIGNALING 20 123 1.356e-05 0.0003565
178 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 22 144 1.428e-05 0.0003732
179 REGULATION OF VASCULATURE DEVELOPMENT 30 233 1.496e-05 0.000389
180 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 18 104 1.506e-05 0.0003892
181 REGULATION OF EPITHELIAL CELL MIGRATION 24 166 1.54e-05 0.000396
182 CEREBRAL CORTEX CELL MIGRATION 11 43 1.602e-05 0.0004096
183 NEURAL CREST CELL MIGRATION 12 51 1.674e-05 0.0004233
184 NEGATIVE REGULATION OF CHEMOTAXIS 12 51 1.674e-05 0.0004233
185 KIDNEY EPITHELIUM DEVELOPMENT 20 125 1.733e-05 0.0004358
186 REGULATION OF BLOOD CIRCULATION 35 295 1.84e-05 0.0004604
187 CARDIAC VENTRICLE DEVELOPMENT 18 106 1.971e-05 0.0004887
188 REGULATION OF ORGANELLE ORGANIZATION 99 1178 1.987e-05 0.0004887
189 REGULATION OF INTRACELLULAR TRANSPORT 60 621 1.977e-05 0.0004887
190 DEVELOPMENTAL GROWTH 38 333 1.996e-05 0.0004887
191 GLAND MORPHOGENESIS 17 97 2.178e-05 0.0005306
192 REGULATION OF KINASE ACTIVITY 71 776 2.202e-05 0.0005337
193 CORONARY VASCULATURE DEVELOPMENT 10 37 2.307e-05 0.0005563
194 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 33 274 2.326e-05 0.0005579
195 NEGATIVE REGULATION OF CELL CELL ADHESION 21 138 2.36e-05 0.0005631
196 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 27 204 2.399e-05 0.0005696
197 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 14 70 2.478e-05 0.0005853
198 RESPONSE TO KETONE 25 182 2.523e-05 0.0005929
199 EPITHELIAL CELL PROLIFERATION 16 89 2.722e-05 0.0006364
200 CELL JUNCTION ASSEMBLY 20 129 2.778e-05 0.0006464
201 EYE DEVELOPMENT 37 326 2.875e-05 0.0006655
202 NEGATIVE REGULATION OF CELL PROLIFERATION 61 643 2.914e-05 0.0006713
203 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 10 38 2.977e-05 0.0006823
204 CELL PROLIFERATION 63 672 3.095e-05 0.0006991
205 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 119 1492 3.077e-05 0.0006991
206 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 23 162 3.091e-05 0.0006991
207 REGULATION OF CELL GROWTH 42 391 3.205e-05 0.0007203
208 RESPONSE TO EXTERNAL STIMULUS 140 1821 3.621e-05 0.0007986
209 ENSHEATHMENT OF NEURONS 16 91 3.619e-05 0.0007986
210 AXON ENSHEATHMENT 16 91 3.619e-05 0.0007986
211 REGULATION OF CELL CELL ADHESION 41 380 3.579e-05 0.0007986
212 REGULATION OF CALCIUM ION TRANSPORT 27 209 3.702e-05 0.0008124
213 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 22 153 3.743e-05 0.0008176
214 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 20 133 4.356e-05 0.0009472
215 ESTROUS CYCLE 7 19 4.394e-05 0.000951
216 SINGLE ORGANISM BEHAVIOR 41 384 4.547e-05 0.000977
217 EPITHELIAL TO MESENCHYMAL TRANSITION 12 56 4.557e-05 0.000977
218 ACTIN FILAMENT BASED MOVEMENT 16 93 4.769e-05 0.001018
219 REGULATION OF CELLULAR COMPONENT BIOGENESIS 69 767 4.884e-05 0.001024
220 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 17 103 4.843e-05 0.001024
221 REGULATION OF MUSCLE ORGAN DEVELOPMENT 17 103 4.843e-05 0.001024
222 REGULATED EXOCYTOSIS 28 224 4.872e-05 0.001024
223 REGULATION OF OSSIFICATION 24 178 4.933e-05 0.001029
224 BONE DEVELOPMENT 22 156 5.058e-05 0.001051
225 INOSITOL LIPID MEDIATED SIGNALING 19 124 5.159e-05 0.001067
226 REGULATION OF NEUROTRANSMITTER LEVELS 25 190 5.226e-05 0.001076
227 REGULATION OF BODY FLUID LEVELS 50 506 5.432e-05 0.001108
228 ACTION POTENTIAL 16 94 5.455e-05 0.001108
229 CELL GROWTH 20 135 5.412e-05 0.001108
230 CARDIAC CHAMBER MORPHOGENESIS 17 104 5.495e-05 0.001112
231 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 71 799 5.616e-05 0.001113
232 IN UTERO EMBRYONIC DEVELOPMENT 35 311 5.569e-05 0.001113
233 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 94 1135 5.621e-05 0.001113
234 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 58 616 5.622e-05 0.001113
235 NEURAL CREST CELL DIFFERENTIATION 14 75 5.552e-05 0.001113
236 LEUKOCYTE ACTIVATION 43 414 5.73e-05 0.00113
237 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 6 14 5.828e-05 0.001144
238 APPENDAGE DEVELOPMENT 23 169 6.068e-05 0.001181
239 LIMB DEVELOPMENT 23 169 6.068e-05 0.001181
240 EPITHELIAL CELL DIFFERENTIATION 49 495 6.149e-05 0.001192
241 REGULATION OF MAPK CASCADE 61 660 6.213e-05 0.0012
242 EMBRYONIC HEMOPOIESIS 7 20 6.438e-05 0.001233
243 AXONAL FASCICULATION 7 20 6.438e-05 0.001233
244 REGULATION OF CELL DEATH 116 1472 6.491e-05 0.001238
245 WOUND HEALING 47 470 6.752e-05 0.001279
246 POSITIVE REGULATION OF CELL GROWTH 21 148 6.789e-05 0.001279
247 DEVELOPMENTAL MATURATION 25 193 6.777e-05 0.001279
248 REGULATION OF CELL ACTIVATION 48 484 6.96e-05 0.001306
249 ADHERENS JUNCTION ASSEMBLY 9 34 7.088e-05 0.001325
250 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 28 229 7.217e-05 0.00134
251 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 11 50 7.284e-05 0.00134
252 REGULATION OF ADHERENS JUNCTION ORGANIZATION 11 50 7.284e-05 0.00134
253 RESPONSE TO PROGESTERONE 11 50 7.284e-05 0.00134
254 CONNECTIVE TISSUE DEVELOPMENT 25 194 7.378e-05 0.001352
255 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 14 77 7.502e-05 0.001369
256 STRIATED MUSCLE CELL DIFFERENTIATION 23 173 8.742e-05 0.001589
257 CELL CHEMOTAXIS 22 162 8.985e-05 0.001627
258 CARDIAC MUSCLE TISSUE DEVELOPMENT 20 140 9.108e-05 0.001643
259 CELL JUNCTION ORGANIZATION 24 185 9.173e-05 0.001648
260 REGULATION OF HOMOTYPIC CELL CELL ADHESION 34 307 9.708e-05 0.001737
261 REGULATION OF HEART CONTRACTION 27 221 9.772e-05 0.001742
262 RESPONSE TO OXYGEN CONTAINING COMPOUND 109 1381 0.0001025 0.00182
263 SECRETION 55 588 0.0001033 0.001828
264 REGULATION OF GTPASE ACTIVITY 61 673 0.0001076 0.001896
265 ADULT LOCOMOTORY BEHAVIOR 14 80 0.0001154 0.002026
266 REGULATION OF CYTOPLASMIC TRANSPORT 47 481 0.0001175 0.002056
267 NEGATIVE REGULATION OF GROWTH 28 236 0.000122 0.002126
268 CELLULAR RESPONSE TO OXYGEN LEVELS 20 143 0.0001227 0.002131
269 ADHERENS JUNCTION ORGANIZATION 13 71 0.0001247 0.002157
270 SKELETAL SYSTEM MORPHOGENESIS 25 201 0.0001311 0.00226
271 SPROUTING ANGIOGENESIS 10 45 0.0001411 0.002399
272 MORPHOGENESIS OF A BRANCHING STRUCTURE 22 167 0.0001413 0.002399
273 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 6 16 0.0001412 0.002399
274 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 16 0.0001412 0.002399
275 NEGATIVE REGULATION OF TRANSPORT 45 458 0.0001436 0.00243
276 MODULATION OF SYNAPTIC TRANSMISSION 33 301 0.000148 0.002495
277 CIRCULATORY SYSTEM PROCESS 38 366 0.0001525 0.002545
278 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 15 92 0.0001526 0.002545
279 VENTRICULAR SEPTUM DEVELOPMENT 11 54 0.0001523 0.002545
280 CELL FATE COMMITMENT 27 227 0.0001534 0.00255
281 EMBRYONIC ORGAN DEVELOPMENT 41 406 0.0001559 0.002582
282 RESPONSE TO ESTRADIOL 20 146 0.0001637 0.002701
283 REGULATION OF CALCIUM ION IMPORT 16 103 0.0001673 0.00275
284 REGULATION OF TRANSFERASE ACTIVITY 79 946 0.0001701 0.002787
285 REGULATION OF SECRETION 62 699 0.0001727 0.00282
286 REGULATION OF NEUROTRANSMITTER TRANSPORT 12 64 0.0001781 0.002897
287 REGULATION OF HYDROLASE ACTIVITY 104 1327 0.0001932 0.003111
288 RESPONSE TO ESTROGEN 26 218 0.0001929 0.003111
289 ACTIN MEDIATED CELL CONTRACTION 13 74 0.0001926 0.003111
290 NEURAL TUBE FORMATION 15 94 0.0001952 0.003133
291 DIGESTIVE SYSTEM DEVELOPMENT 20 148 0.0001973 0.003154
292 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 17 0.000208 0.003315
293 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 11 56 0.0002141 0.003389
294 OUTFLOW TRACT MORPHOGENESIS 11 56 0.0002141 0.003389
295 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 17 116 0.0002189 0.003447
296 REGULATION OF TRANSMEMBRANE TRANSPORT 42 426 0.0002193 0.003447
297 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 13 75 0.0002213 0.003467
298 REGULATION OF PHOSPHOLIPASE C ACTIVITY 9 39 0.000223 0.003471
299 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 9 39 0.000223 0.003471
300 POSITIVE REGULATION OF CATALYTIC ACTIVITY 116 1518 0.0002255 0.003498
301 SPINAL CORD DEVELOPMENT 16 106 0.0002351 0.003631
302 MUSCLE CONTRACTION 27 233 0.0002359 0.003631
303 NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 7 24 0.0002365 0.003631
304 LENS DEVELOPMENT IN CAMERA TYPE EYE 12 66 0.000241 0.003689
305 CYCLIC NUCLEOTIDE METABOLIC PROCESS 11 57 0.0002522 0.003848
306 REGULATION OF HEART RATE 14 86 0.0002549 0.003876
307 REGULATION OF SEQUESTERING OF CALCIUM ION 16 107 0.0002625 0.003967
308 PEPTIDYL AMINO ACID MODIFICATION 71 841 0.0002635 0.003967
309 POSITIVE REGULATION OF CELL ADHESION 38 376 0.0002631 0.003967
310 TUBE FORMATION 18 129 0.0002707 0.004063
311 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 9 40 0.0002738 0.004092
312 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 64 740 0.0002744 0.004092
313 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 8 32 0.000276 0.004095
314 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 12 67 0.000279 0.004095
315 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 50 541 0.0002789 0.004095
316 HOMEOSTASIS OF NUMBER OF CELLS 22 175 0.0002783 0.004095
317 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 50 541 0.0002789 0.004095
318 ACTOMYOSIN STRUCTURE ORGANIZATION 13 77 0.0002899 0.004229
319 RESPONSE TO LIPID 74 888 0.0002894 0.004229
320 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 37 365 0.000297 0.004298
321 CARDIAC SEPTUM MORPHOGENESIS 10 49 0.0002971 0.004298
322 MUSCLE CELL MIGRATION 6 18 0.0002974 0.004298
323 REGULATION OF RESPONSE TO STRESS 112 1468 0.0003083 0.004442
324 PLATELET ACTIVATION 19 142 0.0003206 0.004604
325 REGULATION OF CELL JUNCTION ASSEMBLY 12 68 0.000322 0.00461
326 REGULATION OF ERK1 AND ERK2 CASCADE 27 238 0.0003324 0.004649
327 LEARNING 18 131 0.0003282 0.004649
328 RENAL TUBULE DEVELOPMENT 13 78 0.0003305 0.004649
329 REGULATION OF ION HOMEOSTASIS 24 201 0.0003288 0.004649
330 CELL SUBSTRATE JUNCTION ASSEMBLY 9 41 0.0003337 0.004649
331 REGULATION OF STEM CELL PROLIFERATION 14 88 0.0003259 0.004649
332 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 87 1087 0.0003324 0.004649
333 RETINA DEVELOPMENT IN CAMERA TYPE EYE 18 131 0.0003282 0.004649
334 LACTATION 9 41 0.0003337 0.004649
335 RESPONSE TO HORMONE 74 893 0.0003413 0.00474
336 NEURON RECOGNITION 8 33 0.0003468 0.004802
337 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 23 190 0.0003558 0.004912
338 LYMPHOCYTE ACTIVATION 35 342 0.000358 0.004929
339 REGULATION OF SYNAPSE ASSEMBLY 13 79 0.0003759 0.00516
340 METENCEPHALON DEVELOPMENT 15 100 0.0003904 0.005333
341 NEGATIVE REGULATION OF GENE EXPRESSION 113 1493 0.0003912 0.005333
342 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 26 228 0.000392 0.005333
343 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 16 111 0.0004014 0.005445
344 REGULATION OF CELL MATRIX ADHESION 14 90 0.0004133 0.005557
345 LENS MORPHOGENESIS IN CAMERA TYPE EYE 6 19 0.0004144 0.005557
346 PROTEIN AUTOPHOSPHORYLATION 23 192 0.0004137 0.005557
347 MESONEPHROS DEVELOPMENT 14 90 0.0004133 0.005557
348 ARTERY MORPHOGENESIS 10 51 0.0004178 0.005586
349 SYNAPSE ORGANIZATION 19 145 0.0004191 0.005588
350 FOREBRAIN NEURON DEVELOPMENT 8 34 0.0004317 0.005739
351 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 18 134 0.0004343 0.005757
352 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 62 724 0.0004405 0.005822
353 POSITIVE REGULATION OF KINASE ACTIVITY 45 482 0.0004445 0.005859
354 REGULATION OF VASCULOGENESIS 5 13 0.0004578 0.006018
355 MEMBRANE DEPOLARIZATION 11 61 0.0004667 0.0061
356 POSITIVE REGULATION OF STEM CELL PROLIFERATION 11 61 0.0004667 0.0061
357 ADULT BEHAVIOR 18 135 0.0004757 0.006183
358 METAL ION TRANSPORT 52 582 0.0004751 0.006183
359 NEGATIVE REGULATION OF CELL GROWTH 21 170 0.0004806 0.006229
360 RESPONSE TO ABIOTIC STIMULUS 82 1024 0.0004831 0.006231
361 MUSCLE SYSTEM PROCESS 30 282 0.0004835 0.006231
362 REGULATION OF SYNAPSE ORGANIZATION 16 113 0.0004919 0.006323
363 CELLULAR RESPONSE TO LIPID 43 457 0.0005019 0.006428
364 REGULATION OF PROTEIN LOCALIZATION 77 950 0.0005029 0.006428
365 RESPONSE TO ALCOHOL 36 362 0.0005105 0.006508
366 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 31 296 0.0005135 0.006528
367 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 72 876 0.0005153 0.006533
368 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 7 27 0.0005243 0.006612
369 SUBSTRATE DEPENDENT CELL MIGRATION 7 27 0.0005243 0.006612
370 CARDIAC VENTRICLE MORPHOGENESIS 11 62 0.0005394 0.006784
371 EXOCYTOSIS 32 310 0.000541 0.006785
372 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 24 208 0.0005438 0.006802
373 SECOND MESSENGER MEDIATED SIGNALING 20 160 0.0005564 0.00694
374 SKELETAL MUSCLE ORGAN DEVELOPMENT 18 137 0.0005688 0.007077
375 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 10 53 0.0005766 0.007098
376 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 10 53 0.0005766 0.007098
377 MAMMARY GLAND EPITHELIUM DEVELOPMENT 10 53 0.0005766 0.007098
378 RHYTHMIC PROCESS 31 298 0.0005755 0.007098
379 REGULATION OF PEPTIDE SECRETION 24 209 0.0005829 0.007156
380 REGULATION OF METAL ION TRANSPORT 33 325 0.0005973 0.007294
381 RESPIRATORY SYSTEM DEVELOPMENT 23 197 0.0005958 0.007294
382 NEPHRON DEVELOPMENT 16 115 0.0005994 0.007301
383 REGULATION OF CELL SUBSTRATE ADHESION 21 173 0.0006071 0.007375
384 REGULATION OF VESICLE MEDIATED TRANSPORT 43 462 0.0006277 0.007606
385 REGULATION OF IMMUNE SYSTEM PROCESS 106 1403 0.0006318 0.007635
386 NEGATIVE REGULATION OF BLOOD CIRCULATION 8 36 0.000652 0.007759
387 REGULATION OF SENSORY PERCEPTION 8 36 0.000652 0.007759
388 RESPONSE TO BMP 14 94 0.0006489 0.007759
389 CELLULAR RESPONSE TO BMP STIMULUS 14 94 0.0006489 0.007759
390 REGULATION OF SENSORY PERCEPTION OF PAIN 8 36 0.000652 0.007759
391 POSITIVE CHEMOTAXIS 8 36 0.000652 0.007759
392 TRANSMISSION OF NERVE IMPULSE 10 54 0.0006731 0.007969
393 NEGATIVE REGULATION OF PHOSPHORYLATION 40 422 0.0006719 0.007969
394 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 5 14 0.0006798 0.008028
395 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 9 45 0.0006918 0.008149
396 REGULATION OF ION TRANSPORT 52 592 0.0007027 0.008257
397 MUSCLE CELL DEVELOPMENT 17 128 0.0007064 0.008279
398 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 74 0.000715 0.008318
399 REGULATION OF PHOSPHOLIPASE ACTIVITY 11 64 0.0007133 0.008318
400 CELLULAR RESPONSE TO STRESS 116 1565 0.000713 0.008318
401 REGULATION OF SYNAPTIC PLASTICITY 18 140 0.0007378 0.00854
402 SYNAPTIC SIGNALING 40 424 0.0007365 0.00854
403 REGULATION OF GLIAL CELL PROLIFERATION 6 21 0.0007535 0.0087
404 CHEMICAL HOMEOSTASIS 71 874 0.0007745 0.008898
405 HEART PROCESS 13 85 0.0007744 0.008898
406 ACTIN CYTOSKELETON REORGANIZATION 10 55 0.0007824 0.008967
407 CAMP MEDIATED SIGNALING 8 37 0.000792 0.009054
408 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 18 141 0.000803 0.009157
409 RESPONSE TO RETINOIC ACID 15 107 0.0008101 0.009216
410 CELLULAR RESPONSE TO RETINOIC ACID 11 65 0.0008164 0.009264
411 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 9 46 0.0008183 0.009264
412 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 36 372 0.000841 0.009498
413 HOMEOSTATIC PROCESS 101 1337 0.0008511 0.009589
414 CELL MATRIX ADHESION 16 119 0.0008755 0.00984
415 RESPONSE TO ACID CHEMICAL 32 319 0.0008803 0.00987
416 POSITIVE REGULATION OF MAPK CASCADE 43 470 0.0008878 0.009931
NumGOOverlapSizeP ValueAdj. P Value
1 CYTOSKELETAL PROTEIN BINDING 89 819 7.457e-10 6.875e-07
2 PROTEIN KINASE ACTIVITY 74 640 1.48e-09 6.875e-07
3 KINASE ACTIVITY 89 842 2.953e-09 9.143e-07
4 ACTIN BINDING 51 393 1.355e-08 2.517e-06
5 ENZYME BINDING 151 1737 1.189e-08 2.517e-06
6 RECEPTOR BINDING 132 1476 2.136e-08 3.307e-06
7 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 97 992 2.975e-08 3.949e-06
8 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 17 64 4.483e-08 5.206e-06
9 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 18 81 3.465e-07 3.471e-05
10 PROTEIN COMPLEX BINDING 89 935 3.737e-07 3.471e-05
11 CHEMOREPELLENT ACTIVITY 10 27 9.282e-07 7.839e-05
12 PROTEIN TYROSINE KINASE ACTIVITY 27 176 1.458e-06 0.0001005
13 CELL ADHESION MOLECULE BINDING 28 186 1.38e-06 0.0001005
14 MACROMOLECULAR COMPLEX BINDING 119 1399 1.515e-06 0.0001005
15 HEPARIN BINDING 24 157 5.857e-06 0.0003627
16 SEMAPHORIN RECEPTOR BINDING 8 22 1.377e-05 0.0007995
17 GLYCOSAMINOGLYCAN BINDING 27 205 2.62e-05 0.00141
18 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 60 629 2.883e-05 0.00141
19 MOLECULAR FUNCTION REGULATOR 110 1353 2.831e-05 0.00141
20 PROTEIN HETERODIMERIZATION ACTIVITY 47 468 6.086e-05 0.002827
21 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 36 328 7.388e-05 0.003268
22 PROTEIN DIMERIZATION ACTIVITY 94 1149 8.815e-05 0.003723
23 SULFUR COMPOUND BINDING 28 234 0.0001053 0.003913
24 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 97 1199 0.0001028 0.003913
25 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 55 588 0.0001033 0.003913
26 KINASE BINDING 56 606 0.0001235 0.004201
27 ACTIN FILAMENT BINDING 18 121 0.000119 0.004201
28 ION CHANNEL BINDING 17 111 0.0001266 0.004201
29 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 27 226 0.0001425 0.004415
30 PROTEIN SERINE THREONINE KINASE ACTIVITY 44 445 0.0001471 0.004415
31 GROWTH FACTOR BINDING 18 123 0.0001473 0.004415
32 CORECEPTOR ACTIVITY 9 38 0.0001804 0.005236
33 RIBONUCLEOTIDE BINDING 137 1860 0.0003022 0.008276
34 ADENYL NUCLEOTIDE BINDING 115 1514 0.0003029 0.008276
NumGOOverlapSizeP ValueAdj. P Value
1 CELL PROJECTION 177 1786 6.246e-15 3.648e-12
2 NEURON PROJECTION 111 942 2.424e-14 7.078e-12
3 NEURON PART 134 1265 1.629e-13 3.172e-11
4 AXON 62 418 1.218e-12 1.423e-10
5 CELL JUNCTION 123 1151 9.949e-13 1.423e-10
6 SOMATODENDRITIC COMPARTMENT 74 650 2.927e-09 2.848e-07
7 CELL PROJECTION PART 94 946 2.285e-08 1.906e-06
8 SYNAPSE 79 754 3.47e-08 2.533e-06
9 ANCHORING JUNCTION 57 489 8.891e-08 5.769e-06
10 CELL CELL JUNCTION 48 383 1.067e-07 6.231e-06
11 PROTEINACEOUS EXTRACELLULAR MATRIX 45 356 2.075e-07 1.102e-05
12 CORTICAL CYTOSKELETON 18 81 3.465e-07 1.686e-05
13 EXTRACELLULAR MATRIX 50 426 4.46e-07 1.913e-05
14 DENDRITE 52 451 4.587e-07 1.913e-05
15 CYTOPLASMIC REGION 38 287 5.698e-07 2.218e-05
16 CELL CORTEX 33 238 1.106e-06 4.039e-05
17 INTRINSIC COMPONENT OF PLASMA MEMBRANE 136 1649 1.375e-06 4.725e-05
18 CELL CORTEX PART 21 119 2.181e-06 7.077e-05
19 CELL SURFACE 73 757 2.702e-06 8.305e-05
20 CELL SUBSTRATE JUNCTION 45 398 4.536e-06 0.0001204
21 MEMBRANE MICRODOMAIN 36 288 4.339e-06 0.0001204
22 AXON PART 30 219 4.312e-06 0.0001204
23 SYNAPSE PART 61 610 5.848e-06 0.0001485
24 SITE OF POLARIZED GROWTH 23 149 7.714e-06 0.0001877
25 POSTSYNAPSE 42 378 1.431e-05 0.0003344
26 BASEMENT MEMBRANE 16 93 4.769e-05 0.001071
27 MEMBRANE REGION 94 1134 5.44e-05 0.001177
28 EXTRACELLULAR MATRIX COMPONENT 19 125 5.773e-05 0.001177
29 CELL BODY 49 494 5.846e-05 0.001177
30 CORTICAL ACTIN CYTOSKELETON 12 58 6.569e-05 0.001279
31 EXCITATORY SYNAPSE 25 197 9.481e-05 0.001786
32 ACTIN FILAMENT 13 70 0.0001072 0.001957
33 CELL LEADING EDGE 37 350 0.0001286 0.002276
34 CATION CHANNEL COMPLEX 22 167 0.0001413 0.002426
35 RUFFLE 21 156 0.0001459 0.002435
36 PERINUCLEAR REGION OF CYTOPLASM 58 642 0.000172 0.00279
37 SARCOLEMMA 18 125 0.0001814 0.002863
38 CYTOSKELETON 145 1967 0.0001913 0.00294
39 ACTIN CYTOSKELETON 42 444 0.0005206 0.007795
40 CONTRACTILE FIBER 24 211 0.0006684 0.009453
41 VOLTAGE GATED SODIUM CHANNEL COMPLEX 5 14 0.0006798 0.009453
42 CELL CELL ADHERENS JUNCTION 10 54 0.0006731 0.009453

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 Focal_adhesion_hsa04510 35 199 1.105e-09 5.745e-08
2 Rap1_signaling_pathway_hsa04015 31 206 3.85e-07 7.319e-06
3 MAPK_signaling_pathway_hsa04010 39 295 4.222e-07 7.319e-06
4 PI3K_Akt_signaling_pathway_hsa04151 43 352 9.786e-07 1.272e-05
5 Apelin_signaling_pathway_hsa04371 21 137 2.109e-05 0.0001874
6 Gap_junction_hsa04540 16 88 2.352e-05 0.0001874
7 Calcium_signaling_pathway_hsa04020 25 182 2.523e-05 0.0001874
8 Cell_adhesion_molecules_.CAMs._hsa04514 21 145 5.006e-05 0.0003254
9 Regulation_of_actin_cytoskeleton_hsa04810 26 208 8.934e-05 0.0005124
10 cGMP_PKG_signaling_pathway_hsa04022 22 163 9.854e-05 0.0005124
11 Ras_signaling_pathway_hsa04014 27 232 0.0002199 0.001039
12 cAMP_signaling_pathway_hsa04024 23 198 0.0006397 0.002772
13 Phospholipase_D_signaling_pathway_hsa04072 18 146 0.001208 0.004831
14 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 17 139 0.00178 0.006238
15 ECM_receptor_interaction_hsa04512 12 82 0.001799 0.006238
16 Hedgehog_signaling_pathway_hsa04340 8 47 0.003954 0.01285
17 Cytokine_cytokine_receptor_interaction_hsa04060 25 270 0.008435 0.024
18 Cell_cycle_hsa04110 14 124 0.00877 0.024
19 Oocyte_meiosis_hsa04114 14 124 0.00877 0.024
20 mTOR_signaling_pathway_hsa04150 16 151 0.009644 0.02507
21 FoxO_signaling_pathway_hsa04068 14 132 0.01473 0.03648
22 Hippo_signaling_pathway_multiple_species_hsa04392 5 29 0.02024 0.04785
23 HIF_1_signaling_pathway_hsa04066 11 100 0.02248 0.05082
24 p53_signaling_pathway_hsa04115 8 68 0.03374 0.07309
25 TNF_signaling_pathway_hsa04668 11 108 0.03692 0.0768
26 Cellular_senescence_hsa04218 14 160 0.06091 0.1218
27 Jak_STAT_signaling_pathway_hsa04630 14 162 0.06612 0.1273
28 AMPK_signaling_pathway_hsa04152 11 121 0.0724 0.1345
29 NF_kappa_B_signaling_pathway_hsa04064 9 95 0.08023 0.1439
30 Autophagy_animal_hsa04140 11 128 0.0983 0.1704
31 Adherens_junction_hsa04520 7 72 0.1031 0.173
32 VEGF_signaling_pathway_hsa04370 6 59 0.1072 0.1741
33 Sphingolipid_signaling_pathway_hsa04071 10 118 0.119 0.1876
34 Hippo_signaling_pathway_hsa04390 12 154 0.1471 0.225
35 TGF_beta_signaling_pathway_hsa04350 7 84 0.1835 0.2726
36 ErbB_signaling_pathway_hsa04012 7 85 0.1911 0.276
37 Tight_junction_hsa04530 12 170 0.2337 0.3285
38 Lysosome_hsa04142 9 123 0.2422 0.3314
39 Phosphatidylinositol_signaling_system_hsa04070 7 99 0.3089 0.4119
40 Wnt_signaling_pathway_hsa04310 9 146 0.4201 0.5462
41 Phagosome_hsa04145 9 152 0.4678 0.5777
42 Neuroactive_ligand_receptor_interaction_hsa04080 16 278 0.4743 0.5777
43 Endocytosis_hsa04144 14 244 0.4856 0.5777
44 Mitophagy_animal_hsa04137 4 65 0.4888 0.5777
45 Apoptosis_hsa04210 7 138 0.6484 0.7493
46 Notch_signaling_pathway_hsa04330 2 48 0.753 0.8512
47 Peroxisome_hsa04146 3 83 0.8455 0.8997
48 Necroptosis_hsa04217 5 164 0.953 0.953

Quest ID: 7b8c116d93b5dc84a29a3ff8d5ed564d